A new class of agents for estrogen-receptor-positive breast cancer

Dede N Ekoue^{1

2}, Nisha Unni³, Ganesh V Raj^{1

2}

Affiliations

¹ a Department of Urology , University of Texas Southwestern Medical Center , Dallas , TX , USA.
² b Department of Pharmacology , University of Texas Southwestern Medical Center , Dallas , TX , USA.
³ c Department of Medical Oncology , University of Texas Southwestern Medical Center , Dallas , TX , USA.

Editorial

Dede N Ekoue et al. Expert Rev Clin Pharmacol. 2018 Apr.

. 2018 Apr;11(4):325-328.

doi: 10.1080/17512433.2018.1439736.

Dede N Ekoue^{1

2}, Nisha Unni³, Ganesh V Raj^{1

2}

¹ a Department of Urology , University of Texas Southwestern Medical Center , Dallas , TX , USA.
² b Department of Pharmacology , University of Texas Southwestern Medical Center , Dallas , TX , USA.
³ c Department of Medical Oncology , University of Texas Southwestern Medical Center , Dallas , TX , USA.

No abstract available

Keywords: Estrogen receptor; breast cancer; coregulator modulator; estrogen receptor coregulators; therapy resistance.

Publication types